Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Aug;132(8-9):443-8.
doi: 10.1016/j.mad.2011.08.003. Epub 2011 Aug 22.

Oxidatively modified nucleic acids in preclinical Alzheimer's disease (PCAD) brain

Affiliations

Oxidatively modified nucleic acids in preclinical Alzheimer's disease (PCAD) brain

Mark A Lovell et al. Mech Ageing Dev. 2011 Aug.

Abstract

Previous studies show increased oxidative DNA and RNA damage and diminished 8-oxoguanine glycosylase (OGG1) mediated base excision repair in vulnerable brain regions of mild cognitive impairment and late-stage Alzheimer's disease (LAD) subjects compared to normal control (NC) subjects. Recently, a preclinical stage of AD (PCAD) has been described in which subjects show no overt clinical manifestations of AD but demonstrate significant AD pathology at autopsy. To determine if DNA or RNA oxidation are significantly elevated in PCAD brain we quantified 8-hydroxyguanine (8-OHG) in sections of hippocampus/parahippocamapal gyri in PCAD and NC subjects using immunohistochemistry and confocal microscopy and in superior and middle temporal gyri (SMTG) using gas chromatography/mass spectrometry. To determine if increased DNA oxidation is associated with altered repair capacity, levels of OGG1 protein in HPG were measured by immunohistochemistry and levels of OGG1 mRNA were measured in SMTG using quantitative PCR. Results show significantly increased (p<0.05) 8-OHG immunostaining in DNA and RNA of PCAD HPG and significantly increased 8-OHG in PCAD SMTG. Quantification of OGG1 showed significantly elevated mRNA in PCAD SMTG and a trend toward elevated protein immunostaining in PCAD HPG. Overall, the data suggest oxidative damage to nucleic acids and a compensatory increase in OGG1 expression occur early in the pathogenesis of AD.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Representative confocal micrographs showing RNA associated 8-OHG staining (A) is associated with Tuj-1 positive neurons (C) but not GFAP-positive astrocytes (B). The last panel shows a merged image.
Figure 2
Figure 2
Representative confocal micrographs showing total, RNA-associated, and DNA associated 8-OHG in NC (A) and PCAD (B) hippocampus/parahippocampal gyri. Note elevated immunofluorescence associated with DNA and RNA associated 8-OHG.
Figure 3
Figure 3
Quantification of 8-OHG and OGG1 immunostaining. 8-OHG was significantly (p < 0.05) elevated in RNA and DNA in PCAD subjects compared to age-matched NC subjects. Levels of OGG1 were elevated in PCAD, although the difference was not statistically significant.
Figure 4
Figure 4
Representative confocal micrographs of sections of NC (A) and PCAD (B) hippocampus/parahippocampal gyri immunostained for OGG-1. Note elevated OGG1 immunostaining in PCAD.

References

    1. Aluise CD, Robinson RA, Beckett TL, Murphy MP, Cai J, Pierce WM, Markesbery WR, Butterfield DA. Preclinical Alzheimer disease: brain oxidative stress, Abeta peptide and proteomics. Neurobiol Dis. 2010;39:221–228. - PMC - PubMed
    1. Beelman CA, Parker R. Degradation of mRNA in eukaryotes. Cell. 1995;81:179–183. - PubMed
    1. Bradley MA, Markesbery WR, Lovell MA. Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer disease. Free Radic Biol Med. 2010a;48:1570–1576. - PMC - PubMed
    1. Bradley MA, Xiong-Fister S, Markesbery WR, Lovell MA. Elevated 4-hydroxyhexenal in Alzheimer's disease (AD) progression. Neurobiol Aging 2010b - PMC - PubMed
    1. Bradley MA, Markesbery WR, Lovell MA. Increase levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer's disease (PCAD) Free Radic Biol Med. 2010;48:1570–1576. - PMC - PubMed

Publication types